Orphan diseases
Committed to integrating social responsibility into the study of orphan diseases, Aston Group works hard to develop trusting relationships with both practitioners and patient communities.
This approach allows us to gain valuable insights and put them into practice. Aston Group has an impressive record of marketing and epidemiological research of rare diseases. The studies carried out in the recent years were associated with paroxysmal nocturnal hemoglobinuria, Gaucher's disease, mucopolysaccharidosis II (Hunter's syndrome), Pompe disease and Fabry disease.
Сurrently, our team maintains Patient Registries for 20 orphan diseases in oncology, onco-hematology, autoimmune diseases and lysosomal storage diseases. The Registries contain data on both adult and pediatric patients.
Among the expert health organizations, we collaborate with are:
- Russian Society of Clinical Oncology
- National Society of Hematology
- Hematology Scientific Centre
- Endocrinology Research Centre
- Association of Rheumatologists of Russia
- Society of Pediatricians of Russia
- Nasonova Research Institute of Rheumatology
- Scientific Centre of Children's Health
- Patient organizations representing various rare diseases